We are live on ! Find out more
FMWA

Forvis Mazars Wealth Advisors Portfolio holdings

AUM $5.27B
1-Year Est. Return 18.06%
This Fund
S&P 500
This Quarter Est. Return
-0.62%
1 Year Est. Return
+18.06%
3 Year Est. Return
+51.15%
5 Year Est. Return
+52.01%
10 Year Est. Return
+190.2%
AUM
$2.18B
AUM Growth
+$27.3M
Cap. Flow
+$44M
Cap. Flow %
2.02%
Top 10 Hldgs %
66.55%
Holding
282
New
21
Increased
122
Reduced
94
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 4.85%
2 Healthcare 2.55%
3 Financials 2.35%
4 Consumer Discretionary 1.7%
5 Consumer Staples 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLB icon
276
SLB Ltd
SLB
$73.6B
-6,759
Closed -$216K
TFI icon
277
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.05B
-11,490
Closed -$599K
VBR icon
278
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
-1,463
Closed -$254K
VOT icon
279
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
-1,755
Closed -$415K
WDC icon
280
Western Digital
WDC
$188B
-3,829
Closed -$206K
CFB
281
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
-64,376
Closed -$885K
ALXN
282
DELISTED
Alexion Pharmaceuticals
ALXN
-12,329
Closed -$2.27M

Similar funds

Forvis Mazars Wealth Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Forvis Mazars Wealth Advisors held 282 positions worth $2.18B, up 1.3% from $2.15B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Forvis Mazars Wealth Advisors's Q3 2021 filing shows 21 new, 122 increased, 94 reduced and 10 closed positions. Its largest new stake was Cerner Corp: 12,123 shares worth $855K. The largest sale was Alexion Pharmaceuticals, an estimated $2.27M.

By sector, the portfolio is most concentrated in Technology at 4.8% of assets, up from 4.8% a quarter earlier, followed by Healthcare and Financials.

  • Forvis Mazars Wealth Advisors's largest Q3 2021 buy was Cerner Corp: 12,123 shares worth $855K.
  • Forvis Mazars Wealth Advisors added most to Vanguard FTSE All-World ex-US ETF in Q3 2021, an estimated $9.71M increase.
  • Forvis Mazars Wealth Advisors's biggest Q3 2021 reduction was iShares S&P 500 Growth ETF, cutting an estimated $972K.
  • Forvis Mazars Wealth Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $2.27M.
  • Forvis Mazars Wealth Advisors's ten largest holdings make up 67% of its $2.18B portfolio in Q3 2021.
  • Forvis Mazars Wealth Advisors opened 21 new positions and closed 10 in Q3 2021.
  • Forvis Mazars Wealth Advisors's portfolio value rose 1.3% quarter-over-quarter to $2.18B.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q3 2021, filed 14 Oct 2021.